Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 11—November 2022
CME ACTIVITY - Synopsis

Severe Pneumonia Caused by Corynebacterium striatum in Adults, Seoul, South Korea, 2014–2019

Yun Woo Lee1, Jin Won Huh1, Sang-Bum Hong, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Heungsup Sung, Kyung-Hyun Do, Sang-Oh Lee, Chae-Man Lim, Yang Soo Kim, Younsuck Koh, and Sang-Ho ChoiComments to Author 
Author affiliation: University of Ulsan College of Medicine, Seoul, South Korea

Main Article

Table 5

Outcomes of adult patients with severe Corynebacterium striatum and methicillin-resistant Staphylococcus aureus pneumonia, Seoul, South Korea, 2014–2019*

Outcome Total, n = 130 C. striatum, n = 27 MRSA, n = 103 p value
Death




Total n = 103 n = 27 n = 103 NA
30 days 41 (31.5) 11 (40.7) 30 (29.1) 0.25
60 days 57 (43.8) 14 (48.1) 44 (42.7) 0.61
90 days 68 (52.3) 16 (59.3) 52 (50.5) 0.42
In-hospital
73 (56.2)
19 (70.4)
54 (52.4)
0.09
Death among patient categories
Nonimmunocompromised patients n = 89 n = 13 n = 76 NA
30 days 21 (23.6) 5 (38.5) 16 (21.1) 0.18
60 days 31 (34.8) 5 (38.5) 26 (34.2) 0.76
90 days 40 (44.9) 7 (53.8) 33 (43.4) 0.49
In-hospital 40 (44.9) 7 (53.8) 33 (43.4) 0.49
Immunocompromised patients n = 41 n = 14 n = 27 NA
30 days 20 (48.8) 6 (42.9) 14 (51.9) 0.59
60 days 26 (63.4) 8 (57.1) 18 (66.7) 0.55
90 days 28 (68.3) 9 (64.3) 19 (70.4) 0.73
In-hospital
33 (80.5)
12 (85.7)
21 (77.8)
0.69
Median ICU stay, d (IQR) 14.0 (8.0–26.3) 14.0 (9.0–27.0) 14.0 (8.0–26.0) 0.33
Median hospital stay after ICU admission, d (IQR) 29.5 (14.0–57.0) 30.0 (16.0–81.0) 29.0 (14.0–55.0) 0.48

*Values are no. (%) except as indicated. ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus; NA, not applicable.

Main Article

1These authors contributed equally to this article.

Page created: October 05, 2022
Page updated: October 19, 2022
Page reviewed: October 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external